Decreased cell stiffness after dissociation of intercellular adhesion. by Kristina Seiffert-Sinha (627059)

“…<p>HaCaT cells were cultured in calcium-containing medium for 4 days until reaching confluence (<b>A1, B1, C1</b>), and then calcium-depleted for 2 days (<b>A2, B2, C2</b>), or calcium-depleted for 2 days and then reconstituted in calcium-containing medium for another 2 days (<b>A3, B3, C3</b>). …”

Decreased immunoreactivity of MMP-9 in LBP-treated brain. by Di Yang (126672)

Nesfatin-1 decreased excitability of GI-neurons in DVC. by Jing Dong (102657)

Nur77 knockdown decreases cell viability and proliferation. by Alexa Tenga (2161780)

“…These images correspond to the data in C. Data shown in A are representative of 5 independent experiments; data in B are representative of 4 independent experiments, and data in C and E are representative of 2 independent experiments. …”

Lactic acid decreases extra- and intracellular pH. by Yiwen Xiang (360073)

Ade decreases cell viability and induces cell death. by Shujue Li (466324)

Decreased immunoreactivity of AQP4 in LBP-treated brain. by Di Yang (126672)

“…Note the intense AQP4 staining in vehicle-treated vessels after MCAO (arrows, A), which was decreased in both LBP groups (B&C). …”

BSO and AUR decreased cell viability and clonogenic survival. by Arya Sobhakumari (300950)

Accuracy decreases with response latency after stimulus offset. by Pamela Reinagel (282995)

PARP inhibition causes a decrease in Alt-EJ that is enhanced by Ku70 loss. by Sean M. Howard (687174)

“…Shown are the immunoblot signals for PARylated protein and actin after treatment of U2OS cells with 5 μM of the PARPi Olaparib (2 days). Also shown is the cell cycle profile of siCTRL treated U2OS cells incubated with 5μM Olaparib (Olap), or mock treated (UN) prior to BrdU labeling and PI staining as in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1004943#pgen.1004943.g002" target="_blank">Fig. 2C</a>. …”

APC decreases epithelial cytotoxicity induced by histones but not by NET. by Mona Saffarzadeh (180792)

Decreasing medium osmolarity causes retraction as theoretically predicted. by Nikola Ojkic (651966)

Effect of decreased cell numbers on metabolite peak intensities. by Venugopal Gunda (492731)

MβCD treatment decreases neuroglian stabilization. by Nicholas J. Gibson (173220)

Decreased brain mass in the CD320 KO mouse. by Kaveri Arora (4033364)

MPCs in aged myofibers display decreased myogenic activity. by Grégory Lacraz (370661)

L-2286 treatment decreased the deposition of interstitial collagen. by Laszlo Deres (596720)

Receptor specific silencing decreases NGF induced apoptosis. by Alessandra Micera (294762)

“…(B) Confocal images depicting GFP positive cells (image) and p75^NTR-GFP double-positive cells (insert over the image), re-plated 5 hrs after electroporation. (C–D) Representative histogram for GFP specific staining, in comparison to control siRNA (control cells), showing a decreased p75^NTR positive expression and the related p75^NTR target gene deregulation. …”

Foxa2 expression is decreased in OVA-sensitized mice. by Chuanqi Wei (713106)

Decreasing Mio levels results in abnormal myofibril ultrastructure. by Grzegorz L. Polak (787000)